Th1 epitope selection for clinically effective cancer vaccines.
Saved in:
| Title: | Th1 epitope selection for clinically effective cancer vaccines. |
|---|---|
| Authors: | Disis ML; Tumor Vaccine Group; Center for Translational Medicine in Women's Health; University of Washington ; Seattle, WA USA., Watt WC; Tumor Vaccine Group; Center for Translational Medicine in Women's Health; University of Washington ; Seattle, WA USA., Cecil DL; Tumor Vaccine Group; Center for Translational Medicine in Women's Health; University of Washington ; Seattle, WA USA. |
| Source: | Oncoimmunology [Oncoimmunology] 2014 Dec 13; Vol. 3 (9), pp. e954971. Date of Electronic Publication: 2014 Dec 13 (Print Publication: 2014). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
